Evaluate the Benefit of RUCONEST® in Improving Neurologic Symptoms in Post COVID-19 Infections

Have you Developed Neurological Symptoms Post-COVID?

The purpose of this study is to determine if giving the investigational product, RUCONEST®, to improve symptoms of Post COVID-19 Neurological Symptoms.


The Study

  • Many patients who have been diagnosed with COVID find themselves experiencing neurological symptoms post COVID infection.
  • Symptoms of post COVID neurological symptoms include extreme fatigue, loss of taste and/or smell, brain fog, seizures, tremor, and in some instances strokeStudy Benefits
  • The purpose of the study is to determine if treating subjects with post COVID neurological symptoms with RUCONEST® will improve their neurological symptoms
  • The use of RUCONEST® is being tested to see if the drug can assist in correcting the immune dysfunction that results from a deficit in the immune response due to COVID infection

Study Volunteers Must Meet the Following Criteria

  • Males and females ages 18-75
  • Previous COVID diagnosis
  • Development of neurological symptoms post COVID

Study Participant Expectations

  • Neurological assessments and questionnaires will be completed at each visit
  • Blood samples will be collected throughout the study
  • Subject will be compensated for time and travel
  • Each RUCONEST® infusion could last up to 2 hours
  • Each subject will receive 8 RUCONEST® infusions during study treatment period
  • Each subject will receive a total of 16 infusions
  • Total length of study participation is 19 weeks


  • There is no cost to participate. Patients who qualify may be compensated for time and travel.

Register for a Study

    Why Should I Participate?

    You can contribute to medical research that may lead to new treatment options.

    • You can play a more active role in your own health care.
    • You can obtain medical care during the trial.

    Information on Clinical Research Trials

    A “Clinical Trial” is a research study designed to answer specific questions about investigational treatments or new ways of using known treatments.

    • Physicians conduct clinical trials according to strict rules set by the Food and Drug Administration (FDA) and ethic review.